C-reactive protein, interleukin-6 and pre-eclampsia: large-scale evidence from the GenPE case-control study

References

• Harmon AC, Cornelius DC, LaMarca B. The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond). 2016;130:409–419.
   PubMed Web of Science ®Google Scholar
• Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Am J Obstet Gynecol. 1988;158:80–83.
   PubMed Web of Science ®Google Scholar
• Kassebaum NJ, Bertozzi-Villa A, Lozano R. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:980–1004.
   PubMed Web of Science ®Google Scholar
• Basso O, Rasmussen S, Skjaerven R. Trends in fetal and infant survival following preeclampsia. JAMA. 2006;296:1357–1362.
   PubMed Web of Science ®Google Scholar
• Salam RA, Das JK, Lassi ZS. Diagnosis and management of preeclampsia in community settings in low and middle-income countries. J Family Med Prim Care. 2015;4:501–506.
   PubMedGoogle Scholar
• Bilano VL, Ota E, Souza JP. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One. 2014;9:e91198.
   PubMed Web of Science ®Google Scholar
• Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonat M. 2006;11:309–316.
   PubMed Web of Science ®Google Scholar
• Taylor BD, Tang G, Haggerty CL. Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls. Pregnancy Hypertens. 2016;6:72–78.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.
   PubMed Web of Science ®Google Scholar
• Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:565.
   PubMed Web of Science ®Google Scholar
• Ray JG, Vermeulen MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366:1797–1803.
   PubMed Web of Science ®Google Scholar
• Anderson CM. Preeclampsia: exposing future cardiovascular risk in mothers and their children. J Obstet Gynecol Neonatal Nurs. 2007;36:3–8.
   PubMed Web of Science ®Google Scholar
• Brown MC, Best KE, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28:1–19.
   PubMed Web of Science ®Google Scholar
• Magnussen EB, Vatten LJ, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ. 2007;335:978.
   PubMed Web of Science ®Google Scholar
• Sesso HD, Buring JE, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA. 2003;290:2945–2951.
   PubMed Web of Science ®Google Scholar
• Bautista LE, Lopez-Jaramillo P, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens. 2001;19:857–861.
   PubMed Web of Science ®Google Scholar
• Wu ZM, Yang H, Huang SJ. Pro-inflammatory cytokine-stimulated first trimester decidual cells enhance macrophage-induced apoptosis of extravillous trophoblasts. Placenta. 2012;33:188–194.
   PubMed Web of Science ®Google Scholar
• Szarka A, Rigo J, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010;11:59.
   PubMed Web of Science ®Google Scholar
• Jonsson Y, Ruber M, Ekerfelta C. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol. 2006;70:83–91.
   PubMed Web of Science ®Google Scholar
• Black KD, Horowitz JA. Inflammatory markers and preeclampsia: a systematic review. Nurs Res. 2018;67:242–251.
   PubMed Web of Science ®Google Scholar
• LaMarca B, Cornelius D, Wallace K. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology (Bethesda). 2013;28:225–233.
   PubMed Web of Science ®Google Scholar
• Udenze I, Amadi C, Makwe CC. The role of cytokines as inflammatory mediators in preeclampsia. Pan Afr Med J. 2015;20:219.
   PubMed Web of Science ®Google Scholar
• Lai Z, Kalkunte S, Sharma S. A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice. Hypertension. 2011;57:505–514.
   PubMed Web of Science ®Google Scholar
• Reslan OM, Khalil RA. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovasc Hematol Agents Med Chem. 2010;8(4):204–226.
   PubMedGoogle Scholar
• Martinez-Varea A, Pellicer B, Pellicer A. The maternal cytokine and chemokine profile of naturally conceived gestations is mainly preserved during In vitro fertilization and egg donation pregnancies. J Immunol Res. 2015;2015:128616.
   PubMed Web of Science ®Google Scholar
• Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7:803–815.
   PubMed Web of Science ®Google Scholar
• Ma Y, Ye Y, Gao PJ. Immune imbalance is associated with the development of preeclampsia. Medicine (Baltimore). 2019;98:e15080.
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Jain AK, Rath G. Association of pro- and anti-inflammatory cytokines in preeclampsia. J Clin Lab Anal. 2019;33:e22834.
   PubMed Web of Science ®Google Scholar
• Valencia-Ortega J, Zarate A, Puello E. Placental proinflammatory state and maternal endothelial dysfunction in preeclampsia. Gynecol Obstet Invest. 2019;84:12–19.
   PubMed Web of Science ®Google Scholar
• Rebelo F, Schlussel MM, Kac G. C-reactive protein and later preeclampsia: systematic review and meta-analysis taking into account the weight status. J Hypertens. 2013;31:16–26.
   PubMed Web of Science ®Google Scholar
• Casas JP, Shah T, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008;264:295–314.
   PubMed Web of Science ®Google Scholar
• Pepys MB, Hirschfield GM, Wood SP. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature. 2006;440:1217–1221.
   PubMed Web of Science ®Google Scholar
• Estudio de Genes Candidatos en Preeclampsia. 2005. Available from: http://www.genpe.org/.
   Google Scholar
• Report of the National High Blood Pressure Education Program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1–S22.
   PubMed Web of Science ®Google Scholar
• Akaike, H. Information theory and an extension of the maximum likelihood principle. In: Parzen E., Tanabe K., Kitagawa G., editors. Selected papers of hirotugu akaike. Springer; 1998.
   Google Scholar
• Sakamoto Y, Ishiguro M, Kitagawa G. Akaike information criterion statistics. 1st ed. Springer Netherlands; 1986.
   Google Scholar
• Neyman J, Pearson ES. On the use and interpretation of certain test criteria for purposes of statistical inference: part I. Biometrika. 1928;20A(1/2):175–240.
   Google Scholar
• Bautista LE, Orostegui M, Herran OF. Prevalence and impact of cardiovascular risk factors in Bucaramanga, Colombia: results from the Countrywide Integrated Noncommunicable Disease Intervention Programme (CINDI/CARMEN) baseline survey. Eur J Cardiovasc Prev Rehabil. 2006;13:769–775.
   PubMedGoogle Scholar
• Henderson J, Thompson JH, Whitlock EP. Screening for preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force (Vol. 148). Kaiser Permanente Research Affiliates Evidence-Based Practice Center; 2016; p. 1–133.
   Google Scholar
• Logan CA, Thiel L, Genuneit J. Delivery mode, duration of labor, and cord blood adiponectin, leptin, and c-reactive protein: results of the population-based ulm birth cohort studies. Plos One. 2016;11(2):e0149918.
   PubMed Web of Science ®Google Scholar
• Teran E, Escudero C, Calle A. C-reactive protein during normal pregnancy and preeclampsia. Int J Gynaecol Obstet. 2005;89:299–300.
   PubMed Web of Science ®Google Scholar
• Teran E, Escudero C, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet. 2001;75:243–249.
   PubMed Web of Science ®Google Scholar
• Garcia RG, Celedon J, López-Jaramillo P. Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens. 2007;20:98–103.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Belizan JM. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG. 2000;107:75–83.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Qian C, Bianchi DW. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol. 2004;190(3):707–713.
   PubMed Web of Science ®Google Scholar
• Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ. 1998;316:140–144.
   PubMed Web of Science ®Google Scholar
• Xie C, Yao MZ, Xiong LK. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine. 2011;56:550–559.
   PubMed Web of Science ®Google Scholar
• Lawlor DA, Smith GD, Ebrahim S. Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women’s Heart and Health Study. Thromb Haemost. 2005;93:955–963.
   PubMed Web of Science ®Google Scholar
• Nazmi A, Victora CG. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health. 2007;7:212.
   PubMed Web of Science ®Google Scholar